BTCY - Biotricity Inc Revenue Growth YoY (Last 12 Months)

Promotion costs are creating pressure, as confirmed by the percentage change in sales over the last 12 months compared to the previous 12 months on GURU.Markets, where the 29.90 mark serves as the current indicator for Biotricity, Inc. (BTCY). A SaaS model with predictable cash flow, along with the Bioflux system—which integrates wearable sensors with physician oversight—mitigates these risks. ARR growth is supported by the expansion of the IT subscription base for cardiac monitoring.
Biotricity - analytical breakdowns and key metrics (BTCY)

This indicator measures business expansion rates by comparing current annual revenue with the same period last year to identify real demand dynamics. By analyzing the annual revenue growth trend over a rolling 12-month period, an investor can assess the effectiveness of Biotricity, Inc. (BTCY) IoT platform implementation in cardiac monitoring, which determines the company's capitalization potential through the optimization of medical logistics.